Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Body dysmorphia is common in women with PCOS, affecting their quality of life.

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

Hair loss and excessive growth treated with various options, including new laser technology.

Ovarian hyperthecosis can cause high testosterone and symptoms like hair loss, and surgery can help improve these symptoms.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Treatment balancing hormones stopped hair loss in most women with androgenetic alopecia.

A female dog with mixed male and female traits was treated successfully with surgery.

Men seeking hair transplants show higher perfectionism and body dysmorphic disorder symptoms.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Early physical exams are crucial for timely Klinefelter syndrome diagnosis.

Iron deficiency causes many symptoms, and transferrin saturation is a better diagnostic marker than hemoglobin.

The T/SHBG ratio may be a useful marker for androgen activity in women with androgenetic alopecia.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

African-American girls tend to start puberty earlier than white girls, possibly due to increased androgen production.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

The surgical technique of scalp advancement and pretrichial brow lift shortens the forehead and lifts brows, is good for women and transgender women with high foreheads, but not recommended for men and has some risks.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

Finasteride may affect female fertility by altering gene activity.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

A 10-year-old girl's symptoms improved after surgery to remove a benign adrenal tumor.

A man with both Klinefelter syndrome and primary hyperparathyroidism showed a rare combination of symptoms and genetic patterns.

A rare ovarian tumor caused early puberty signs in a 1-year-old girl, but surgery reduced hormone levels.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.